Corvus Pharmaceuticals, Inc. Stock Issued During Period, Shares, New Issues
Corvus Pharmaceuticals, Inc. (CRVS) reported Stock Issued During Period, Shares, New Issues of 1.46 million shares for the 1-month period ending 2021-09-30, per its 10-K filed 2024-03-19.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2024-03-19
- 2021-09-30: Stock Issued During Period, Shares, New Issues 1 month 1.46M shares.
- 2016-03-29: Stock Issued During Period, Shares, New Issues 4.70M shares.
| Period end | Stock Issued During Period, Shares, New Issues | Stock Issued During Period, Shares, New Issues 1 month |
|---|---|---|
| 2021-09-30 | 1.46M shares 10-K · filed 2024-03-19 | |
| 2016-03-29 | 4.70M shares 10-Q · filed 2016-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Apnimed, Inc. (APMD) | United States | $0.899B |